MarketCap
Facebook
X
TelegramAnnual report 2022
added 08-16-2022
Global Cord Blood Corporation Operating Expenses 2011-2026 | CO
Annual Operating Expenses Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 451 M | 436 M | 473 M | 419 M | 475 M | 352 M | 327 M | 270 M | 235 M | 210 M | 159 M | 138 M |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 475 M | 138 M | 329 M |
Quarterly Operating Expenses Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 107 M | - | - | - | 102 M | - | - | - | 121 M | - | - | - | 95.1 M | - | - | - | 113 M | - | - | - | 90.3 M | - | - | - | 81.8 M | - | - | - | 64.3 M | - | - | - | 58 M | 58.3 M | - | - | 54.4 M | 46.5 M | 41.6 M | 41.6 M | 39 M | 36.8 M | 38.2 M |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 121 M | 36.8 M | 69.9 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 2.81 | -5.39 % | $ 91.2 K |  USA |
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 23.0 | -1.5 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 28.5 | -8.06 % | $ 307 M |  China |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
45.3 M | - | - | $ 79.8 M | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.13 | -3.26 % | $ 1.44 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 32.44 | 0.22 % | $ 901 M | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 218.83 | -0.41 % | $ 160 B | USA |
 |
Celcuity
CELC
|
113 M | $ 101.7 | -2.37 % | $ 4.01 B | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 206.95 | 0.83 % | $ 23 B | USA |
 |
DexCom
DXCM
|
1.69 B | $ 68.33 | 0.24 % | $ 26.4 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
484 M | $ 19.43 | -5.57 % | $ 1.04 B | USA |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.4 | -4.76 % | $ 295 M | Israel |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.98 B | $ 103.37 | 0.02 % | $ 19.2 B | USA |
 |
Interpace Biosciences
IDXG
|
21.8 M | $ 1.82 | - | $ 7.98 M | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 22.74 | -1.41 % | $ 688 M | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 66.24 | -1.39 % | $ 4.58 B | USA |
 |
Guardant Health
GH
|
226 M | $ 104.16 | -0.83 % | $ 12.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B |  Niderland |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 400.6 | 0.04 % | $ 28.9 B |  Schweiz |
 |
NeoGenomics
NEO
|
382 M | $ 11.36 | -1.26 % | $ 1.44 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Natera
NTRA
|
258 M | $ 206.93 | -2.23 % | $ 20.4 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 165.55 | -8.67 % | $ 8.51 B | USA |
 |
IDEXX Laboratories
IDXX
|
1.25 B | $ 645.07 | -0.23 % | $ 53.2 B | USA |
 |
Illumina
ILMN
|
3.69 B | $ 117.29 | -1.7 % | $ 18.6 B | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 177.19 | -2.89 % | $ 32.1 B | USA |
 |
OPKO Health
OPK
|
217 M | $ 1.23 | 0.86 % | $ 854 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 31.87 | -3.2 % | $ 20 B | Niderland |
|
Biodesix
BDSX
|
106 M | $ 10.18 | -2.12 % | $ 1.32 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 286.87 | 0.86 % | $ 24.1 B | USA |
 |
ENDRA Life Sciences
NDRA
|
10.8 M | $ 3.7 | -0.77 % | $ 1.99 M | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 131.48 | -9.05 % | $ 10.8 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
285 M | $ 27.58 | -5.6 % | $ 1.16 B | USA |
 |
Biomerica
BMRA
|
5.64 M | $ 2.23 | -3.88 % | $ 5.12 M | USA |